Paper31410844
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
Lipton RB and 7 others. Headache, 2019. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study. Papers, record 31410844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31410844
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Migraine Disorders | Major topic |
| Needs Assessment | Major topic |
| Treatment Outcome | Major topic |
| Adult | |
| Cross-Sectional Studies | |
| Female | |
| Humans | |
| Longitudinal Studies | |
| Male | |
| Middle Aged | |
| Surveys and Questionnaires | |
| United States |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Dr. Reddy's Laboratories group of companies | International | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29368949 | Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. | Cephalalgia | 2018 | https://conductscience.org/library/papers/29368949 | PubMed |
| 2 | 23879870 | Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. | Headache | 2013 | https://conductscience.org/library/papers/23879870 | PubMed |
| 3 | 25246519 | Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. | Cephalalgia | 2015 | https://conductscience.org/library/papers/25246519 | PubMed |
| 4 | 21457175 | Emergency department consultations for patients with neurological emergencies. | Eur J Neurol | 2011 | https://conductscience.org/library/papers/21457175 | PubMed |
| 5 | 11554951 | Migraine diagnosis and treatment: results from the American Migraine Study II. | Headache | 2001 | https://conductscience.org/library/papers/11554951 | PubMed |
| 6 | 12656703 | Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. | Headache | 2003 | https://conductscience.org/library/papers/12656703 | PubMed |
| 7 | 21187794 | Assessing the impact of migraine onset on work productivity. | J Occup Environ Med | 2011 | https://conductscience.org/library/papers/21187794 | PubMed |
| 8 | 1727198 | Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. | JAMA | 1992 | https://conductscience.org/library/papers/1727198 | PubMed |
| 9 | 29445880 | The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility. | J Headache Pain | 2018 | https://conductscience.org/library/papers/29445880 | PubMed |
| 10 | 15531016 | Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). | Clin Ther | 2004 | https://conductscience.org/library/papers/15531016 | PubMed |
| 11 | 25881676 | Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. | Headache | 2015 | https://conductscience.org/library/papers/25881676 | PubMed |
| 12 | 19239676 | Validity and reliability of the Migraine-Treatment Optimization Questionnaire. | Cephalalgia | 2009 | https://conductscience.org/library/papers/19239676 | PubMed |
| 13 | 23808937 | Effects of switching acute treatment on disability in migraine patients using triptans. | Headache | 2013 | https://conductscience.org/library/papers/23808937 | PubMed |
| 14 | 30341895 | Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. | Headache | 2018 | https://conductscience.org/library/papers/30341895 | PubMed |
| 15 | 8857711 | Classification of daily and near-daily headaches: field trial of revised IHS criteria. | Neurology | 1996 | https://conductscience.org/library/papers/8857711 | PubMed |
| 16 | 11554952 | Prevalence and burden of migraine in the United States: data from the American Migraine Study II. | Headache | 2001 | https://conductscience.org/library/papers/11554952 | PubMed |
| 17 | 15265257 | Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. | Curr Med Res Opin | 2004 | https://conductscience.org/library/papers/15265257 | PubMed |
| 18 | 15846257 | Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). | Am Heart J | 2005 | https://conductscience.org/library/papers/15846257 | PubMed |
| 19 | 24932784 | What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study. | PLoS One | 2014 | https://conductscience.org/library/papers/24932784 | PubMed |
| 20 | 4650929 | Indices of relative weight and obesity. | J Chronic Dis | 1972 | https://conductscience.org/library/papers/4650929 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42639778 | Efficacy and safety of Dingluo nasal drops for the acute treatment of migraine: a pilot randomized trial. | J Tradit Chin Med | 2026 | https://conductscience.org/library/papers/42639778 | PubMed |
| 42143245 | Rimegepant for the acute treatment of migraine: a systematic review and meta-analysis. | J Headache Pain | 2026 | https://conductscience.org/library/papers/42143245 | PubMed |
| 41794348 | Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model. | Int J Pharm | 2026 | https://conductscience.org/library/papers/41794348 | PubMed |
| 41721442 | Unmet treatment needs in migraine: Results of the OVERCOME (US) study. | Headache | 2026 | https://conductscience.org/library/papers/41721442 | PubMed |
| 41300216 | Green Light and Transcranial Direct Current Stimulation in Migraine Patients: A Preliminary Randomized Control Trial. | Brain Sci | 2025 | https://conductscience.org/library/papers/41300216 | PubMed |
| 41186275 | Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine study. | Headache | 2026 | https://conductscience.org/library/papers/41186275 | PubMed |
| 41068578 | Adherence status and influencing factors of acute and preventive pharmacotherapy among migraine patients in China. | J Headache Pain | 2025 | https://conductscience.org/library/papers/41068578 | PubMed |
| 39030417 | A Retrospective Analysis of Disease Epidemiology, Comorbidity Burden, Treatment Patterns, and Healthcare Resource Utilization of Migraine in the United Arab Emirates. | Pain Ther | 2024 | https://conductscience.org/library/papers/39030417 | PubMed |
| 38865075 | Light Therapy in Chronic Migraine. | Curr Pain Headache Rep | 2024 | https://conductscience.org/library/papers/38865075 | PubMed |
| 38822165 | Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy. | CNS Drugs | 2024 | https://conductscience.org/library/papers/38822165 | PubMed |
| 38370478 | Real-world observations and impacts of Chinese herbal medicine for migraine: results of a registry-based cohort study. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38370478 | PubMed |
| 38349136 | Update on gepants for the treatment of chronic migraine. | J Chin Med Assoc | 2024 | https://conductscience.org/library/papers/38349136 | PubMed |
| 38289612 | Impact of Neurolens Use on the Quality of Life in Individuals With Headaches: A Randomized Double-Masked, Cross-Over Clinical Trial. | Transl Vis Sci Technol | 2024 | https://conductscience.org/library/papers/38289612 | PubMed |
| 36944864 | Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China. | Pain Ther | 2023 | https://conductscience.org/library/papers/36944864 | PubMed |
| 36438031 | Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36438031 | PubMed |
| 36239038 | Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial. | Headache | 2022 | https://conductscience.org/library/papers/36239038 | PubMed |
| 36068494 | Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. | J Headache Pain | 2022 | https://conductscience.org/library/papers/36068494 | PubMed |
| 35859654 | Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia. | Neurobiol Pain | 2022 | https://conductscience.org/library/papers/35859654 | PubMed |
| 35468729 | Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials. | J Headache Pain | 2022 | https://conductscience.org/library/papers/35468729 | PubMed |
| 35343590 | Real-world assessment of the relationship between migraine-related disability and healthcare costs in the United States. | Headache | 2022 | https://conductscience.org/library/papers/35343590 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31410844
GET https://conductscience.org/api/papers/v1/31410844/references?page=2